13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001172661-24-004656
Total Value
$339.8M
Positions
30
Other Managers
2
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEUROGENE INC | NGNE | 1,004,291 | $42.1M | 12.40% |
| 2 | ABIVAX SA | AAVXF | 2,128,773 | $24.5M | 7.22% |
| 3 | PLIANT THERAPEUTICS INC | PLRX | 1,910,121 | $21.4M | 6.30% |
| 4 | EVOLUS INC | EOLS | 1,170,000 | $19.0M | 5.58% |
| 5 | VIRIDIAN THERAPEUTICS INC | VRDN | 750,000 | $17.1M | 5.02% |
| 6 | CYTOKINETICS INC | CYTK | 316,000 | $16.7M | 4.91% |
| 7 | KALVISTA PHARMACEUTICALS INC | KALV | 1,299,503 | $15.0M | 4.43% |
| 8 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 1,326,234 | $14.8M | 4.35% |
| 9 | CONTEXT THERAPEUTICS INC | CNTX | 6,934,982 | $13.6M | 4.00% |
| 10 | ZURA BIO LTD | ZURA | 3,263,672 | $13.3M | 3.90% |
| 11 | ORUKA THERAPEUTICS INC | ORKA | 514,659 | $12.6M | 3.71% |
| 12 | MERUS N V | N5749R100 | 250,000 | $12.5M | 3.68% |
| 13 | OLEMA PHARMACEUTICALS INC | OLMA | 1,000,000 | $11.9M | 3.51% |
| 14 | IONIS PHARMACEUTICALS INC | IONS | 255,000 | $10.2M | 3.01% |
| 15 | AUTOLUS THERAPEUTICS PLC | AUTL | 2,811,955 | $10.2M | 3.00% |
| 16 | UROGEN PHARMA LTD | URGN | 758,786 | $9.6M | 2.84% |
| 17 | OPTINOSE INC | 68404V100 | 12,861,136 | $8.6M | 2.54% |
| 18 | ARCELLX INC | ACLX | 100,000 | $8.4M | 2.46% |
| 19 | ARCELLX INC | ACLX | 100,000 | $8.4M | 2.46% |
| 20 | DIANTHUS THERAPEUTICS INC | DNTH | 275,000 | $7.5M | 2.22% |
| 21 | OUTLOOK THERAPEUTICS INC | OTLK | 1,293,028 | $6.9M | 2.03% |
| 22 | JASPER THERAPEUTICS INC | JSPRW | 322,380 | $6.1M | 1.78% |
| 23 | VOYAGER THERAPEUTICS INC | VYGR | 959,953 | $5.6M | 1.65% |
| 24 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.2M | 1.54% |
| 25 | TSCAN THERAPEUTICS INC | TCRX | 1,016,375 | $5.1M | 1.49% |
| 26 | UNICYCIVE THERAPEUTICS INC | UNCY | 8,559,000 | $3.5M | 1.03% |
| 27 | PROMIS NEUROSCIENCES INC | PMN | 2,790,698 | $3.5M | 1.03% |
| 28 | CARTESIAN THERAPEUTICS INC | RNAC | 200,000 | $3.2M | 0.95% |
| 29 | VISTAGEN THERAPEUTICS INC | VTGN | 674,075 | $2.0M | 0.60% |
| 30 | ELIEM THERAPEUTICS INC | CLYM | 248,168 | $1.3M | 0.37% |